Knowledge Hub

Valuing intellectual and developmental disability (IDD) service providers requires a nuanced understanding of the diverse care settings and reimbursement environments that define this segment of the healthcare and social services sector. IDD services encompass a wide array of models, including residential and group homes that offer 24‑hour support, adult day programs focused on habilitation and community engagement, adult foster care and shared‑living arrangements, as well as

The hospice industry plays a critical role in the U.S. healthcare system, providing compassionate, end-of-life care to patients with terminal illnesses. Hospice services include pain management, symptom relief, counseling, and support for both patients and their families. The industry is heavily regulated and deeply influenced by reimbursement policy, but it continues to be a highly active sector for M&A, driven by demographic tailwinds and the ongoing aging of the U.S. popul

The ambulatory surgery center (ASC) industry has experienced steady growth driven by the shift of procedures from inpatient hospitals to lower-cost outpatient settings, supported by advancements in minimally invasive surgical techniques and favorable reimbursement trends. In the M&A landscape, ASCs are highly attractive to private equity firms and strategic healthcare buyers due to their scalable business models, high margins, and potential for consolidating fragmented market

The diagnostic imaging center industry is a critical component of the healthcare sector, providing essential services for the detection, diagnosis, and monitoring of various medical conditions. These facilities utilize advanced imaging technologies such as X-rays, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET) to produce detailed images of the body’s internal structures. M&A activity in this sector has remained s

The dermatology industry has been a hotbed of M&A activity for a decade now, driven by strong cash flow, predictable patient demand, and a balanced mix of medical and elective services. Private equity firms and strategic buyers are actively consolidating the space, targeting practices with multiple providers, ancillary revenue streams, and scalable operations. As competition increases, well-managed dermatology groups with diversified services and payer stability are commandin

The infusion therapy industry is experiencing strong growth due to increasing demand for specialty biologics, chronic disease management, and a continued shift toward lower-cost outpatient and home-based care settings. M&A activity has accelerated as private equity firms and strategic buyers seek scalable platforms with specialty pharmacy integration, in-network payer contracts, and strong referral pipelines. Valuations tend to be highest for providers offering a broad therap